Clinical trial
Efficacy and Safety of Dihydroartemisinin/Piperaquine (Artekin®) for the…
NCT00373607 · Institute of Tropical Medicine, Belgium, Other · Completed
Key facts
| NCT number | NCT00373607 |
|---|---|
| Title | Efficacy and Safety of Dihydroartemisinin/Piperaquine (Artekin®) for the Treatment of Uncomplicated Malaria in Peru |
| Official title | Phase 3a: Efficacy, Safety, and Tolerability of Dihydroartemisinin/Piperaquine (Artekin®) for the Treatment of Uncomplicated Plasmodium Falciparum Malaria in the Peruvian Amazon Region |
| Lead sponsor | Institute of Tropical Medicine, Belgium, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Malaria |
| Intervention type | Drug |
| Interventions | Dihydroartemisin-piperaquine, Mefloquine + Artesunate |
| Enrollment | 522 |
| Start date | Jul 1, 2003 |
| Primary completion | Jul 1, 2005 |
| Completion | Jul 1, 2005 |
| First posted | Sep 8, 2006 |
| Last update posted | Sep 14, 2010 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: